RXRX vs IBRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 27, 2026

RXRX

37.5
AI Score
VS
RXRX Wins

IBRX

35.0
AI Score

Investment Advisor Scores

RXRX

38score
Recommendation
EXTENDED

IBRX

35score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric RXRX IBRX Winner
Forward P/E 0 123.4568 Tie
PEG Ratio 0 0 Tie
Revenue Growth -60.1% 93.9% IBRX
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 37.5/100 35.0/100 RXRX
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED AVOID NEW MONEY RXRX

Relative Price Performance (Last 90 Days)

RXRX 1M: +19.1% · 3M: +1.6% IBRX 1M: +27.5% · 3M: +13.7%

Current Technical Phase

RXRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.9% over 20 days), RSI 60

RSI (14): 59.6 · Price: $4.03

IBRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.5% over 20 days), RSI 69

RSI (14): 69.3 · Price: $10.14

Fundamentals Snapshot

Metric RXRX IBRX
Market Cap — —
Forward P/E -4.5 -73.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.6% 0.9%
Gross Margin -7.2% 1.0%
Operating Margin -17.6% -1.2%
EPS -1.02 -0.95
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RXRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.